BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9221567)

  • 41. Pharmacology of purine nucleoside analogues.
    Plunkett W; Gandhi V
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S67-74. PubMed ID: 9137959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients.
    Zinzani PL; Magagnoli M; Moretti L; Battista R; Ronconi F; De Renzo A; Zaccaria A; Gentilini P; Guardigni L; Gherlinzoni F; Cellini C; Fattori PP; Bendandi M; Bocchia M; Aitini E; Tura S
    Haematologica; 1999 Nov; 84(11):1002-6. PubMed ID: 10553160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
    Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
    Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.
    Johnson SA
    Hematol J; 2004; 5 Suppl 1():S50-61. PubMed ID: 15079153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
    Saven A
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral fludarabine.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(21):2317-23. PubMed ID: 14524733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fludarabine-based combination therapies for Waldenström's macroglobulinemia.
    Tedeschi A; Alamos SM; Ricci F; Greco A; Morra E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):67-70. PubMed ID: 19362977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
    Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
    Churn M; Clough V
    Clin Oncol (R Coll Radiol); 2001; 13(4):273-5. PubMed ID: 11554624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular and clinical pharmacology of fludarabine.
    Gandhi V; Plunkett W
    Clin Pharmacokinet; 2002; 41(2):93-103. PubMed ID: 11888330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fludarabine: a review.
    Hood MA; Finley RS
    DICP; 1991 May; 25(5):518-24. PubMed ID: 2068837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fludarabine: a review of the clear benefits and potential harms.
    Lukenbill J; Kalaycio M
    Leuk Res; 2013 Sep; 37(9):986-94. PubMed ID: 23787174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Future prospects for fludarabine-containing regimens in the treatment of hematological cancers.
    Hillmen P
    Hematol J; 2004; 5 Suppl 1():S76-86. PubMed ID: 15079156
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse and beneficial immunological effects of purine nucleoside analogues.
    Dighiero G
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
    Zinzani PL; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S
    Eur J Haematol; 1995 Feb; 54(2):120-3. PubMed ID: 7698295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic lymphoproliferative disorders.
    Catovsky D
    Curr Opin Oncol; 1995 Jan; 7(1):3-11. PubMed ID: 7696361
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.
    Chun HG; Leyland-Jones B; Cheson BD
    J Clin Oncol; 1991 Jan; 9(1):175-88. PubMed ID: 1702143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies.
    Lärfars G; Udén-Blohmé AM; Samuelsson J
    Br J Haematol; 1996 Sep; 94(4):709-12. PubMed ID: 8826898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cryptococcal meningitis and intracranial tuberculoma in a patient with Waldenstrom's macroglobulinemia treated with fludarabine.
    Costa P; Luzzati R; Nicolato A; Perboni G; Scalzini A; Lazzarini L; Forghieri ME; Aitini E; Zinzani PL
    Leuk Lymphoma; 1998 Feb; 28(5-6):617-20. PubMed ID: 9613995
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic lymphoproliferative disorders: chronic lymphocytic leukemia and hairy-cell leukemia.
    Keating MJ
    Curr Opin Oncol; 1993 Jan; 5(1):35-41. PubMed ID: 8427892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.